Mechanisms Controlling Divergent Fates of Ovarian Follicles and Fertility

控制卵巢卵泡和生育力不同命运的机制

基本信息

  • 批准号:
    9527155
  • 负责人:
  • 金额:
    $ 38.51万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-05-15 至 2019-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The goal of the proposed research is to determine the mechanisms by which the FOXO boxO transcription factors, FSH and ovarian---derived growth factors (activin and BMP2) regulate ovarian follicular growth and apoptosis and hence fertility. By disrupting the Foxo1 and Foxo3 genes selectively in granulosa cells, we have generated mice that are infertile with a novel phenotype that is distinct from all other known mutations in granulosa cells. The infertile phenotype can be traced to: 1) Reduced follicle growth and apoptosis leading us to discover a new paradigm: that FOXO1/3 act in granulosa cells to mediate both follicle maturation and apoptosis, and that these distinct functions of FOXO1/3 are tightly linked to specific interactions with either the activin or BMP2 signaling pathways, respectively. 2) Defective oocyte development that appears to be mediated primarily by changes in metabolic/endocrine factors emanating from the mutant cumulus cells. Analyses of cumulus and oocyte functions in the mutant mice should lead us to discover specific FOXO1/3 targets that regulate of oocyte maturation and 3) Alterations in ovarian feedback to the pituitary leading to suppressed FSH that appears to be mediated by a novel ovarian---derived factor that is not inhibin. Characterizing a new Fshb suppressor(s) has far---ranging implications for developing alternative contraceptive targets. Thus, the Foxo1/3 conditional KO mice provide a unique model in which to determine the physiological, molecular and biochemical mechanisms by which these transcriptional regulators impact apoptosis, oocyte maturation and ovarian production of a novel factor(s) that suppresses pituitary Fshb expression. To analyze these functions of Foxo1/3 that control reproductive success, we propose the following Specific Aims: I) Determine how interactions between FSH, activin, BMP2 and FOXO1/3 impact granulosa cell apoptosis in intact follicles. II) Determine the changes in cumulus cell and oocyte functions in the Foxo1/3 mutant mice that impact fertility. III) Characterize the novel Fshb inhibitory factor(s that emanate from the Foxo1/3 mutant ovaries.
描述(由申请人提供):本研究的目的是确定FOXO boxO转录因子、FSH和卵巢衍生生长因子(激活素和BMP 2)调节卵巢卵泡生长和凋亡以及生育力的机制。通过在颗粒细胞中选择性地破坏Foxo1和Foxo3基因,我们已经产生了不育小鼠,其具有不同于颗粒细胞中所有其他已知突变的新表型。不孕表型可以追溯到:1)卵泡生长和凋亡减少,导致我们发现了一个新的范例:FOXO 1/3在颗粒细胞中起作用,介导卵泡成熟和凋亡,FOXO 1/3的这些不同功能分别与激活素或BMP 2信号通路的特异性相互作用密切相关。2)卵母细胞发育缺陷,似乎主要由突变卵丘细胞产生的代谢/内分泌因子的变化介导。对突变小鼠卵丘和卵母细胞功能的分析应使我们发现调节卵母细胞成熟的特异性FOXO 1/3靶点; 3)卵巢对垂体的反馈改变,导致FSH受抑制,这似乎是由一种新的卵巢衍生因子介导的,而不是卵泡刺激素。表征一种新的Fshb抑制剂对开发替代避孕目标具有深远的影响。因此,Foxo 1/3条件性KO小鼠提供了一种独特的模型,其中确定这些转录调节因子影响细胞凋亡、卵母细胞成熟和卵巢产生抑制垂体Fshb表达的新因子的生理、分子和生化机制。为了分析Foxo 1/3控制生殖成功的这些功能,我们提出了以下具体目标:I)确定FSH、激活素、BMP 2和Foxo 1/3之间的相互作用如何影响完整卵泡中的颗粒细胞凋亡。II)确定影响生育力的Foxo 1/3突变小鼠中卵丘细胞和卵母细胞功能的变化。III)表征源自Foxo 1/3突变卵巢的新Fshb抑制因子。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Neuregulin 1 Regulates Proliferation of Leydig Cells to Support Spermatogenesis and Sexual Behavior in Adult Mice.
Neuregulin 1 调节间质细胞的增殖以支持成年小鼠的精子发生和性行为。
  • DOI:
    10.1210/en.2016-1478
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Umehara,Takashi;Kawashima,Ikko;Kawai,Tomoko;Hoshino,Yumi;Morohashi,Ken-Ichirou;Shima,Yuichi;Zeng,Wenxian;Richards,JoAnneS;Shimada,Masayuki
  • 通讯作者:
    Shimada,Masayuki
Creatine enhances the duration of sperm capacitation: a novel factor for improving in vitro fertilization with small numbers of sperm.
肌酸可延长精子获能的持续时间:这是改善少量精子体外受精的新因素。
  • DOI:
    10.1093/humrep/dey081
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Umehara,Takashi;Kawai,Tomoko;Goto,Masaaki;Richards,JoAnneS;Shimada,Masayuki
  • 通讯作者:
    Shimada,Masayuki
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JoAnne Stewart Richards其他文献

JoAnne Stewart Richards的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JoAnne Stewart Richards', 18)}}的其他基金

Novel Aspect of Androgen Action in Ovarian Cell Function and Dysfunction
雄激素在卵巢细胞功能和功能障碍中作用的新方面
  • 批准号:
    10172961
  • 财政年份:
    2019
  • 资助金额:
    $ 38.51万
  • 项目类别:
Novel Aspect of Androgen Action in Ovarian Cell Function and Dysfunction
雄激素在卵巢细胞功能和功能障碍中作用的新方面
  • 批准号:
    10415947
  • 财政年份:
    2019
  • 资助金额:
    $ 38.51万
  • 项目类别:
Novel Aspect of Androgen Action in Ovarian Cell Function and Dysfunction
雄激素在卵巢细胞功能和功能障碍中作用的新方面
  • 批准号:
    10640129
  • 财政年份:
    2019
  • 资助金额:
    $ 38.51万
  • 项目类别:
Novel Aspect of Androgen Action in Ovarian Cell Function and Dysfunction
雄激素在卵巢细胞功能和功能障碍中作用的新方面
  • 批准号:
    10006016
  • 财政年份:
    2019
  • 资助金额:
    $ 38.51万
  • 项目类别:
Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis
类固醇激素调节卵巢癌的进展和转移
  • 批准号:
    8923209
  • 财政年份:
    2014
  • 资助金额:
    $ 38.51万
  • 项目类别:
Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis
类固醇激素调节卵巢癌的进展和转移
  • 批准号:
    9538594
  • 财政年份:
    2014
  • 资助金额:
    $ 38.51万
  • 项目类别:
Mechanisms Controlling Divergent Fates of Ovarian Follicles and Fertility
控制卵巢卵泡和生育力不同命运的机制
  • 批准号:
    8694652
  • 财政年份:
    2014
  • 资助金额:
    $ 38.51万
  • 项目类别:
Mechanisms Controlling Divergent Fates of Ovarian Follicles and Fertility
控制卵巢卵泡和生育力不同命运的机制
  • 批准号:
    9273274
  • 财政年份:
    2014
  • 资助金额:
    $ 38.51万
  • 项目类别:
Mechanisms Controlling Divergent Fates of Ovarian Follicles and Fertility
控制卵巢卵泡和生育力不同命运的机制
  • 批准号:
    9070506
  • 财政年份:
    2014
  • 资助金额:
    $ 38.51万
  • 项目类别:
Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis
类固醇激素调节卵巢癌的进展和转移
  • 批准号:
    8756182
  • 财政年份:
    2014
  • 资助金额:
    $ 38.51万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 38.51万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.51万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 38.51万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.51万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 38.51万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 38.51万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.51万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 38.51万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 38.51万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.51万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了